We are live on ! Find out more
AIM

Acrospire Investment Management Portfolio holdings

AUM $33K
1-Year Est. Return 24.6%
This Fund
S&P 500
This Quarter Est. Return
+6.54%
1 Year Est. Return
+24.6%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$135M
AUM Growth
-$9.79M
Cap. Flow
-$12.3M
Cap. Flow %
-9.13%
Top 10 Hldgs %
2.07%
Holding
2,503
New
514
Increased
755
Reduced
669
Closed
506

Sector Composition

Rank Sector Weight
1 Healthcare 14.58%
2 Industrials 13.9%
3 Financials 12.71%
4 Technology 11.23%
5 Consumer Discretionary 10.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IONS icon
1376
Ionis Pharmaceuticals
IONS
$9.28B
$28K 0.02%
1,200
+500
+71% +$16.1K
MAS icon
1377
Masco
MAS
$14.7B
$28K 0.02%
900
-1,900
-68% -$59.9K
MPX
1378
DELISTED
Marine Products Corp
MPX
$28K 0.02%
+3,294
New +$27.1K
WHG icon
1379
Westwood Holdings Group
WHG
$184M
$28K 0.02%
543
-298
-35% -$17K
WSR
1380
DELISTED
Whitestone REIT
WSR
$28K 0.02%
1,855
-1,100
-37% -$15K
XRAY icon
1381
Dentsply Sirona
XRAY
$2.31B
$28K 0.02%
450
-500
-53% -$30.8K
INFN
1382
DELISTED
Infinera Corporation Common Stock
INFN
$28K 0.02%
2,500
-800
-24% -$10.5K
CHS
1383
DELISTED
Chicos FAS, Inc.
CHS
$28K 0.02%
2,594
-18,406
-88% -$215K
CPXX
1384
DELISTED
CELATOR PHARMACEUTICALS INC. COMMON STOCK
CPXX
$28K 0.02%
+932
New +$18.9K
DBVT
1385
DBV Technologies
DBVT
$882M
$27K 0.02%
82
+30
+58% +$9.72K
DLX icon
1386
Deluxe
DLX
$1.11B
$27K 0.02%
400
-800
-67% -$50.8K
CBIO
1387
Crescent Biopharma
CBIO
$618M
$27K 0.02%
+37
New +$25.5K
EGRX
1388
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$27K 0.02%
700
-300
-30% -$12.5K
PTR
1389
DELISTED
PETROCHINA COMPANY LIMITED ADS (REP 100 H SHARES)
PTR
$27K 0.02%
400
-100
-20% -$6.88K
CYOU
1390
DELISTED
Changyou.com Limited American Depositary Share
CYOU
$27K 0.02%
+1,357
New +$25.8K
ANFI
1391
DELISTED
AMIRA NATURE FOODS LTD
ANFI
$27K 0.02%
+3,600
New +$27.7K
ICE icon
1392
Intercontinental Exchange
ICE
$87.2B
$26K 0.02%
+500
New +$25.2K
ING icon
1393
ING
ING
$102B
$26K 0.02%
2,500
-1,600
-39% -$19K
ITIC
1394
Investors Title Co
ITIC
$534M
$26K 0.02%
+277
New +$25.9K
PTEN icon
1395
Patterson-UTI
PTEN
$4.16B
$26K 0.02%
1,200
-500
-29% -$9.42K
RRC icon
1396
Range Resources
RRC
$9.33B
$26K 0.02%
+600
New +$24.6K
UAN icon
1397
CVR Partners
UAN
$1.26B
$26K 0.02%
+316
New +$26.1K
VNOM icon
1398
Viper Energy
VNOM
$14.8B
$26K 0.02%
1,379
+269
+24% +$4.98K
LUB
1399
DELISTED
Luby's Inc.
LUB
$26K 0.02%
+5,227
New +$25.8K
MNTA
1400
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$26K 0.02%
+2,411
New +$24.9K

Similar funds

Acrospire Investment Management's Q2 2016 Portfolio in Review

As of Q2 2016, Acrospire Investment Management held 2,503 positions worth $135M, down 6.8% from $144M the previous quarter. Its ten largest holdings account for 2.1% of the portfolio.

Acrospire Investment Management withdrew a net $12.3M in Q2 2016, closing 506 positions and reducing 669 holdings. Its most notable exit was State Street SPDR S&P 500 ETF Trust, an estimated $7.73M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 13% a quarter earlier, followed by Industrials and Financials.

Against the trend, Acrospire Investment Management opened a new position in Unifirst Corp worth $276K.

  • Acrospire Investment Management's largest Q2 2016 buy was Unifirst Corp: 2,389 shares worth $276K.
  • Acrospire Investment Management added most to Ribbon Communications in Q2 2016, an estimated $234K increase.
  • Acrospire Investment Management's biggest Q2 2016 reduction was Stepan Co, cutting an estimated $264K.
  • Acrospire Investment Management fully exited State Street SPDR S&P 500 ETF Trust in Q2 2016, selling an estimated $7.73M.
  • Acrospire Investment Management's ten largest holdings make up 2.1% of its $135M portfolio in Q2 2016.
  • Acrospire Investment Management opened 514 new positions and closed 506 in Q2 2016.
  • Acrospire Investment Management's portfolio value fell 6.8% quarter-over-quarter to $135M.

Based on Acrospire Investment Management's 13F filing for Q2 2016, filed 9 Aug 2016.